yahoo Press
RBC Capital Raises its Price Target on Moderna (MRNA)
Images
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational. Moderna, Inc. (NASDAQ:MRNA) is one of the 10 Best Performing American Stocks in June 2026. On July 7, 2026, RBC Capital raised the firm's price target on Moderna, Inc. (NASDAQ:MRNA) to $45 from $38 and kept a Sector Perform rating on the shares as part of a broader Q2 earnings preview for biotech. RBC said the biotech sector has gained considerable momentum, helped by strong data expanding innovative spaces and perceptions of improving FDA flexibility and stability. The firm added that Q2 earnings are shaping up to be seasonally strong, with multiple opportunities for beats and continued M&A activity. On June 26, Piper Sandler raised the firm's price target on Moderna, Inc. (NASDAQ:MRNA) to $77 from $69 previously and kept an Overweight rating on the shares. Copyright: nexusplexus / 123RF Stock Photo On June 25, Moderna announced research and early development updates at its Science Day event. The company said it is balancing near-term growth with long-term innovation, supported by its four approved products, infectious disease launches, geographic expansion, and late-stage pipeline opportunities, including investigational intismeran autogene therapy and propionic acidemia therapeutic. Moderna also said its Scientific Intelligence Engine uses data, AI, and machine learning, automation, and robotics to accelerate discovery and improve operations. Moderna, Inc. (NASDAQ:MRNA) provides messenger RNA medicines in the United States, Europe, and internationally. While we acknowledge the potential of MRNA as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 33 Stocks That Should Double in 3 Years and Cathie Wood 2026 Portfolio: 10 Best Stocks to Buy. Disclosure: None. Follow Insider Monkey on Google News.
Comments
You must be logged in to comment.